JOURNAL OF THE CZECH PHARMACEUTICAL SOCIETY AND THE SLOVAK PHARMACEUTICAL SOCIETY

Čes. slov. farm. 2024, 73(3):193-198 | DOI: 10.36290/csf.2024.030

Available diagnostic tests in the pharmacy and the role of the pharmacist

Eliška Kolmanová1, 2, Ondřej Tesař1
1 Katedra sociální a klinické farmacie, Farmaceutická fakulta UK v Hradci Králové
2 Lékárny HERBA, s. r. o.

The topic of in vitro diagnostic tests is a relatively robust area of medical devices. It includes tests used in the providing of healthcare, i.e., intended for healthcare professionals, and a group of tests intended directly for consumers (Direct-To-Consumer tests). The subject of the following article is diagnostic tests intended for home in vitro self-testing of patients in the Czech Republic. The aim is to present a basic overview of the available tests, to present the principle of diagnostic tests and in selected groups of tests to summarise the most important information for the correct performance of tests that should be part of pharmaceutical care.

Keywords: diagnostic device, pharmaceutical care, self-testing.

Accepted: September 23, 2024; Published: October 8, 2024  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kolmanová E, Tesař O. Available diagnostic tests in the pharmacy and the role of the pharmacist. Čes. slov. farm. 2024;73(3):193-198. doi: 10.36290/csf.2024.030.
Download citation
PDF will be unlocked 8.10.2025

References

  1. Buss VH, Deeks LS, Shield A, et al. Analytical quality and effectiveness of point-of-care testing in community pharmacies: A systematic literature review. Res Social Adm Pharm. 2019;15(5):483-95. Go to original source... Go to PubMed...
  2. Albasri A, Van den Bruel A, Hayward G, et al. Impact of point-of-care tests in community pharmacies: a systematic review and meta-analysis. BMJ Open. 2020;10(5):e034298. Go to original source... Go to PubMed...
  3. O'Neill K, Fleming G, Scott M, et al. C-reactive protein point of care testing in community pharmacy: Observational study of a Northern Ireland pilot. Pharm Pract (Granada). 2022; 20(4):2711. Go to original source... Go to PubMed...
  4. Sim TF, Chalmers L, Czarniak P, et al. Point-of-care C-reactive protein testing to support the management of respiratory tract infections in community pharmacy: A feasibility study. Res Social Adm Pharm. 2021; 17(10):1719-1726. Go to original source... Go to PubMed...
  5. Tidy EJ, Shine B, Oke J, et al. Home self-testing kits: helful or harmful? Br J Gen Pract. 2018;68(673):360-1. Go to original source... Go to PubMed...
  6. Hinzmann R. Direct-to-consumer testing - benefits for consumers, people with disease and public health. Clin Chem Lab Med. 2023;61(4):703-8. Go to original source... Go to PubMed...
  7. Stanczyk FZ, Mandelbaum RS, Lobo RA. Potential pitfalls of reproductive direct-to-consumer testing. F S Rep. 2022;3(1):3-7. Go to original source... Go to PubMed...
  8. Zákon č. 375/2022 Sb. Zákon o zdravotnických prostředcích a diagnostických zdravotnických prostředcích in vitro - znění od 22. 12. 2022. In: Zákony pro lidi.cz [Internet]. © AION CS 2010-2024 [cited 2024 Apr 16]. Available from: https://www.zakonyprolidi.cz
  9. Nařízení Evropského parlamentu a Rady (EU) 2017/746 ze dne 5. dubna 2017 o diagnostických zdravotnických prostředcích in vitro a o zrušení směrnice 98/79/ES a rozhodnutí Komise 2010/227/EU In: Document 32017R0746 [cited 2024 Apr 16]. Available from: https://eur-lex.europa.eu
  10. Pohanka M. Point-of-Care Diagnoses and Assays Based on Lateral Flow Test. Int J Anal Chem [Internet]. 2021 [cited 2024 May 14]. Available from: doi: 10.1155/2021/6685619 Go to original source...
  11. Göselová J, Blažková M, Holubová B et al. Imunodetekce v laterálním toku na membráně. Chem Listy. 2014;108:114-9.
  12. Pohanka M. Diagnostické metody v klinické biochemii pro point-of-care použití. In: Klinická biochemie a biochemické diagnostické metody: učební text pro vysokoškolskou výuku. Brno: Univerzita obrany v Brně; 2022. p.46-60.
  13. Cytiva. Pads for lateral flow assays. [Internet]. [Downloaded 2024 Apr 17] Available from: https://www.cytivalifesciences.com/en/us/solutions/diagnostics/immunodiagnostics/immunoassay-rapid-test-components
  14. Jenkins L. Lateral flow assays and precision diagnostics. [Internet]. 2018; [cited 2024 Apr 17]. Available from: https://www.cytivalifesciences.com/en/us/news-center/lateral-flow-and-precision-diagnostics-10001
  15. Yasukawa T, Mizutani F, Suzuki M. Point of care testing apparatus for immunosensing. In: Mitsubayashi K, Niwa O, editors. Chemical, Gas, and Biosensors for the Internet of Things and Related Applications. Amsterdam: Elsevier; 2019. p.193-205. Go to original source...
  16. Amerongen A, Veen J, Arends HA et al. Lateral Flow Immunoassays. In: Vashist SK, Luong JHT. Handbook of Immunoassay Technologies. Approaches, Performances and Applications. Amsterdam: Elsevier; 2018. p.157-182. Go to original source...
  17. Mak WCH, Beni V, Turner APF. Lateral-flow technology: From visual to instrumentál. TrAC Trend in Analytical Chemistry. 2016;79:297-305. Go to original source...
  18. Erba Mannheim. Diagnostické proužky PHAN. [Internet]. [Cited 2024 Apr 25]. Available from: https://www.erbalachema.com/produkty-a-reseni/mocova-analyza/diagnosticke-prouzky-phan/
  19. Gnoth C, Johnson S. Strips of Hope: Accuracy of Home Pregnancy Tests and New Developments. Geburtshilfe Frauenheilkd. 2014;74(7):661-9. Go to original source... Go to PubMed...
  20. Trávník P. Detekce plodnosti a těhotenství - v čem, může pomoci lékárník? Prakt. lékáren. 2017;13(3):125-8. Go to original source...
  21. Su HW, Yi YC, Wei TY et al. Detection of ovulation, a review of currently available methods. Bioeng Transl Med. 2017;2(3):238-46. Go to original source... Go to PubMed...




Czech and Slovak Pharmacy

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.